Amicogen flagged as disclosure violator over withdrawn share sale, control-change deal
Bitget2026/09/28 10:19- Amicogen was designated a disclosure-rule violator on Sept. 29, 2026 for reversing two prior market disclosures.
- The breaches involved withdrawals of a third-party allotment paid-in capital increase, disclosed June 22, 2026, withdrawn Aug. 4, 2026.
- It also withdrew a contract tied to a change of control, originally disclosed June 29, 2026, withdrawn Aug. 4, 2026.
- Regulators assessed 7.0 penalty points, taking the company’s trailing 12-month total to 7.0.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CNN Enters Generative AI Partnership with Google
US Stock Market Movement | Nvidia-backed AI pharmaceutical company Iambic Therapeutics (IAM.US) debuts on Nasdaq, surging over 11% after opening
As of press time, the stock is up more than 11%, trading at $17.77.
US Stock Market Movement | 3D Printing Materials Supplier Amaero (AMRO.US) Debuts on US Stock Market, Trading Halt Triggered After Opening
Amaero, a manufacturer specializing in titanium and refractory metal powders for 3D printing in the defense and aerospace sectors, has gone public on the US stock market.
